- Home
- MCRB vs CNF Comparison
MCRB vs CNF Comparison
Compare MCRB & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCRB | CNF |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 34.6M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | MCRB | CNF |
|---|---|---|
| Price | $2.53 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 72.7K | 6.4K |
| Earning Date | 11-04-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.42 | $1.37 |
| 52 Week High | $29.98 | $6.49 |
Technical Indicators
Market Signals| Indicator | MCRB | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 21.14 | 44.31 |
| Support Level | N/A | $1.74 |
| Resistance Level | $9.53 | $2.14 |
| Average True Range (ATR) | 0.24 | 0.15 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 7.70 | 61.64 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.